Crohn disease-associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae

Journal of Clinical Investigation

Volumn 121, Issue 3, 2011, Pages 966-975

  Chassaing, Benoit ^a,b   Rolhion, Nathalie ^a   De Vallée, Amélie ^a   Salim, Sa'ad Y ^c   Prorok Hamon, Maelle ^d   Neut, Christel ^e   Campbell, Barry J ^d   Söderholm, Johan D ^c   Hugot, Jean Pierre ^f   Colombel, Jean Frédéric ^e   Darfeuille Michaud, Arlette ^a,b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b Institut Universitaire de Technologie   (France)

^c LINKÖPING UNIVERSITY   (Sweden)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e UNIVERSITÉ DE LILLE   (France)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADHERENT INVASIVE ESCHERICHIA COLI; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM PILUS; CONTROLLED STUDY; CROHN DISEASE; ENTEROINVASIVE ESCHERICHIA COLI; FEMALE; FIMBRIA; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OPERON; PEYER PATCH; PREVALENCE; PRIORITY JOURNAL; SURFACE PROPERTY;

EID: 79952230127     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44632     Document Type: Article

References (52)

1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621.
2. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007;117(3):514-521. (Pubitemid 46348505)
3. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152):427-434. (Pubitemid 47123518)
4. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134(2):577-594. (Pubitemid 351173057)
5. Darfeuille-Michaud A, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998;115(6):1405-1413. (Pubitemid 28545991)
6. Swidsinski A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122(1):44-54. (Pubitemid 34049193)
7. Martin HM, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004;127(1):80-93. (Pubitemid 38962277)
8. Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun. 1999;67(9):4499-4509. (Pubitemid 29400425)
9. Darfeuille-Michaud A, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127(2):412-421. (Pubitemid 39091889)
10. Martinez-Medina M, et al. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. Inflamm Bowel Dis. 2009;15(6):872-882.
11. Baumgart M, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. Isme J. 2007;1(5):403-418. (Pubitemid 47373247)
12. Sasaki M, et al. Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest. 2007;87(10):1042-1054. (Pubitemid 47429187)
13. Eaves-Pyles T, et al. Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol. 2008;298(5-6):397-409. (Pubitemid 351734791)
14. Carvalho FA, et al. Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med. 2009;206(10):2179-2189.
15. Barnich N, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest. 2007;117(6):1566-1574. (Pubitemid 46871341)
16. Barnich N, Boudeau J, Claret L, Darfeuille-Michaud A. Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease. Mol Microbiol. 2003;48(3):781-794. (Pubitemid 36819062)
17. Boudeau J, Barnich N, Darfeuille-Michaud A. Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol. 2001;39(5):1272-1284. (Pubitemid 32225137)
18. Rolhion N, Carvalho FA, Darfeuille-Michaud A. OmpC and the sigma(E) regulatory pathway are involved in adhesion and invasion of the Crohn's disease-associated Escherichia coli strain LF82. Mol Microbiol. 2007;63(6):1684-1700. (Pubitemid 46426710)
19. Rolhion N, et al. Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion. Gut. 2010;59(10):1355-1362.
20. Miquel S, et al. Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82. PLoS One. 2010;5(9). pii: e12714.
21. Morson BC. The early histological lesion of Crohn's disease. Proc R Soc Med. 1972;65(1):71-72.
22. Gullberg E, Soderholm JD. Peyer's patches and M cells as potential sites of the inflammatory onset in Crohn's disease. Ann N Y Acad Sci. 2006;1072:218-232. (Pubitemid 44448455)
23. Kraehenbuhl JP, Neutra MR. Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol. 2000;16:301-332. (Pubitemid 32037509)
24. Marra A, Isberg RR. Invasin-dependent and invasin-independent pathways for translocation of Yersinia pseudotuberculosis across the Peyer's patch intestinal epithelium. Infect Immun. 1997;65(8):3412-3421. (Pubitemid 27342430)
25. Inman LR, Cantey JR. Specific adherence of Escherichia coli (strain RDEC-1) to membranous (M) cells of the Peyer's patch in Escherichia coli diarrhea in the rabbit. J Clin Invest. 1983;71(1):1-8. (Pubitemid 13170231)
26. Isberg RR, Leong JM. Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell. 1990;60(5):861-871.
27. Jones BD, Ghori N, Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J Exp Med. 1994;180(1):15-23. (Pubitemid 24181051)
28. Terahara K, et al. Comprehensive gene expression profiling of Peyer's patch M cells, villous M-like cells, and intestinal epithelial cells. J Immunol. 2008;180(12):7840-7846.
29. Hase K, et al. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature. 2009;462(7270):226-230.
30. Baumler AJ, Tsolis RM, Heffron F. The lpf fimbrial operon mediates adhesion of Salmonella typhimurium to murine Peyer's patches. Proc Natl Acad Sci U S A. 1996;93(1):279-283. (Pubitemid 26038143)
31. Sansonetti PJ, Arondel J, Cantey JR, Prevost MC, Huerre M. Infection of rabbit Peyer's patches by Shigella flexneri: effect of adhesive or invasive bacterial phenotypes on follicle-associated epithelium. Infect Immun. 1996;64(7):2752-2764. (Pubitemid 26226843)
32. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev. 1991;4(1):80-128. (Pubitemid 21920389)
33. Kerneis S, Bogdanova A, Kraehenbuhl JP, Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science. 1997;277(5328):949-952. (Pubitemid 27366679)
34. Martinez-Argudo I, Sands C, Jepson MA. Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system. Cell Microbiol. 2007;9(6):1538-1546. (Pubitemid 46774024)
35. Barreau F, et al. CARD15/NOD2 is required for Peyer's patches homeostasis in mice. PLoS ONE. 2007;2(6):e523.
36. Van Kruiningen HJ, Ganley LM, Freda BJ. The role of Peyer's patches in the age-related incidence of Crohn's disease. J Clin Gastroenterol. 1997;25(2):470-475. (Pubitemid 27528135)
37. Salim SY, et al. CD83+CCR7- dendritic cells accumulate in the subepithelial dome and internalize translocated Escherichia coli HB101 in the Peyer's patches of ileal Crohn's disease. Am J Pathol. 2009;174(1):82-90.
38. Keita AV, et al. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease. J Pathol. 2008;215(2):135-144. (Pubitemid 351786032)
39. Torres AG, et al. Identification and characterization of lpfABCC'DE, a fimbrial operon of enterohemorrhagic Escherichia coli O157:H7. Infect Immun. 2002;70(10):5416-5427.
40. Norris TL, Kingsley RA, Bumler AJ. Expression and transcriptional control of the Salmonella typhimurium lpf fimbrial operon by phase variation. Mol Microbiol. 1998;29(1):311-320. (Pubitemid 28318583)
41. Jordan DM, Cornick N, Torres AG, Dean-Nystrom EA, Kaper JB, Moon HW. Long polar fimbriae contribute to colonization by Escherichia coli O157:H7 in vivo. Infect Immun. 2004;72(10):6168-6171. (Pubitemid 39303737)
42. Bringer MA, Barnich N, Glasser AL, Bardot O, Darfeuille-Michaud A. HtrA stress protein is involved in intramacrophagic replication of adherent and invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease. Infect Immun. 2005;73(2):712-721. (Pubitemid 40165726)
43. Glasser AL, Boudeau J, Barnich N, Perruchot MH, Colombel JF, Darfeuille-Michaud A. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun. 2001;69(9):5529-5537. (Pubitemid 32786488)
44. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol. 2004;99(12):2393-2404. (Pubitemid 40039371)
45. Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B, Nielsen H. Increased short- and long-term risk of inflammatory bowel disease after Salmonella or Campylobacter gastroenteritis. Gastroenterology. 2009;137(2):495-501.
46. Porter CK, Tribble DR, Aliaga PA, Halvorson HA, Riddle MS. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology. 2008;135(3):781-786.
47. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A. 2000;97(12):6640-6645. (Pubitemid 30412767)
48. Guzman LM, Belin D, Carson MJ, Beckwith J. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol. 1995;177(14):4121-4130.
49. Hogardt M, Trebesius K, Geiger AM, Hornef M, Rosenecker J, Heesemann J. Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. J Clin Microbiol. 2000;38(2):818-825. (Pubitemid 30082687)
50. Hitotsubashi S, Fujii Y, Yamanaka H, Okamoto K. Some properties of purified Escherichia coli heat-stable enterotoxin II. Infect Immun. 1992;60(11):4468-4474.
51. Lo D, et al. Cell culture modeling of specialized tissue: identification of genes expressed specifically by follicle-associated epithelium of Peyer's patch by expression profiling of Caco-2/Raji co-cultures. Int Immunol. 2004;16(1):91-99. (Pubitemid 38054630)
52. Gullberg E, et al. Expression of specific markers and particle transport in a new human intestinal M-cell model. Biochem Biophys Res Commun. 2000;279(3):808-813. (Pubitemid 32042860)